Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristin G Print

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Clinical Breast Cancer|October 21, 2016
Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast TumorsAnita Muthukaruppan, Annette Lasham, Kathryn J Woad, et al.
Clinical Breast Cancer|October 15, 2019
A Predictor of Early Disease Recurrence in Patients With Breast Cancer Using a Cell-free RNA and Protein Liquid BiopsyAnnette Lasham, Sandra J Fitzgerald, Nicholas Knowlton, et al.
Molecular Cancer Therapeutics|August 10, 2004
Transcriptome analysis of endometrial cancer identifies peroxisome proliferator-activated receptors as potential therapeutic targetsCathrine M Holland, Samir A Saidi, Amanda L Evans, et al.
International Journal of Cancer|April 14, 2016
A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell lineAnnette Lasham, Sunali Y Mehta, Sandra J Fitzgerald, et al.
Fertility and Sterility|May 20, 2014
In the secretory endometria of women, luminal epithelia exhibit gene and protein expressions that differ from those of glandular epitheliaGloria E Evans, José A Martínez-Conejero, Gregory T M Phillipson, et al.
The American Journal of Pathology|August 9, 2008
Endometrial-peritoneal interactions during endometriotic lesion establishmentM Louise Hull, Claudia Rangel Escareno, Jane M Godsland, et al.
Stem Cells (Dayton, Ohio)|June 8, 2012
Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancersAnna L Stratford, Kristen Reipas, Kaiji Hu, et al.
Frontiers in Immunology|March 3, 2020
Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor TypesEric D Routh, Ashok K Pullikuth, Guangxu Jin, et al.
Oncotarget|July 19, 2018
Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypesSunali Y Mehta, Brianna C Morten, Jisha Antony, et al.
Frontiers in Immunology|October 17, 2022
Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signaturesSultana Mehbuba Hossain, Gregory Gimenez, Peter A Stockwell, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Clinical Breast Cancer|October 21, 2016
Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast TumorsAnita Muthukaruppan, Annette Lasham, Kathryn J Woad, et al.
Clinical Breast Cancer|October 15, 2019
A Predictor of Early Disease Recurrence in Patients With Breast Cancer Using a Cell-free RNA and Protein Liquid BiopsyAnnette Lasham, Sandra J Fitzgerald, Nicholas Knowlton, et al.
Molecular Cancer Therapeutics|August 10, 2004
Transcriptome analysis of endometrial cancer identifies peroxisome proliferator-activated receptors as potential therapeutic targetsCathrine M Holland, Samir A Saidi, Amanda L Evans, et al.
International Journal of Cancer|April 14, 2016
A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell lineAnnette Lasham, Sunali Y Mehta, Sandra J Fitzgerald, et al.
Fertility and Sterility|May 20, 2014
In the secretory endometria of women, luminal epithelia exhibit gene and protein expressions that differ from those of glandular epitheliaGloria E Evans, José A Martínez-Conejero, Gregory T M Phillipson, et al.
The American Journal of Pathology|August 9, 2008
Endometrial-peritoneal interactions during endometriotic lesion establishmentM Louise Hull, Claudia Rangel Escareno, Jane M Godsland, et al.
Stem Cells (Dayton, Ohio)|June 8, 2012
Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancersAnna L Stratford, Kristen Reipas, Kaiji Hu, et al.
Frontiers in Immunology|March 3, 2020
Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor TypesEric D Routh, Ashok K Pullikuth, Guangxu Jin, et al.
Oncotarget|July 19, 2018
Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypesSunali Y Mehta, Brianna C Morten, Jisha Antony, et al.
Frontiers in Immunology|October 17, 2022
Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signaturesSultana Mehbuba Hossain, Gregory Gimenez, Peter A Stockwell, et al.
Pageof 8